{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:44:29Z","timestamp":1794008669322,"version":"4.8.0"},"reference-count":52,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,2,14]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>FVL platelet-poor and platelet-rich plasma have a reduced threshold for the activation of blood coagulation, which is modulated by TFPI\u03b1. Prothrombinase assembled with FVL is less susceptible to inhibition by TFPI\u03b1 than is prothrombinase assembled with FV.<\/jats:p>","DOI":"10.1182\/bloodadvances.2016002295","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T01:40:32Z","timestamp":1487036432000},"page":"386-395","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":20,"title":["Reduced prothrombinase inhibition by tissue factor pathway inhibitor contributes to the factor V Leiden hypercoagulable state"],"prefix":"10.1182","volume":"1","author":[{"given":"Jeremy P.","family":"Wood","sequence":"first","affiliation":[{"name":"Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Baumann Kreuziger","sequence":"additional","affiliation":[{"name":"Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI; and"},{"name":"Department of Medicine, Hematology and Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E. R.","family":"Ellery","sequence":"additional","affiliation":[{"name":"Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Maroney","sequence":"additional","affiliation":[{"name":"Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan E.","family":"Mast","sequence":"additional","affiliation":[{"name":"Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI; and"},{"name":"Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2017,2,13]]},"reference":[{"issue":"40","key":"2019111607195916200_B1","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1021\/bi00492a016","article-title":"Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor","volume":"29","author":"Komiyama","year":"1990","journal-title":"Biochemistry"},{"issue":"28","key":"2019111607195916200_B2","doi-asserted-by":"crossref","first-page":"17132","DOI":"10.1016\/S0021-9258(17)44879-4","article-title":"Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin","volume":"265","author":"Monkovi\u0107","year":"1990","journal-title":"J Biol Chem"},{"issue":"3","key":"2019111607195916200_B3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/CIRCULATIONAHA.113.003191","article-title":"Factor Xa activation of factor V is of paramount importance in initiating the coagulation system: lessons from a tick salivary protein","volume":"128","author":"Schuijt","year":"2013","journal-title":"Circulation"},{"issue":"5091","key":"2019111607195916200_B4","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/214923a0","article-title":"Relationship between factor V and activated factor X in the generation of prothrombinase","volume":"214","author":"Barton","year":"1967","journal-title":"Nature"},{"issue":"5","key":"2019111607195916200_B5","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1182\/blood.V54.5.1015.bloodjournal5451015","article-title":"Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorder","volume":"54","author":"Miletich","year":"1979","journal-title":"Blood"},{"issue":"21","key":"2019111607195916200_B6","doi-asserted-by":"crossref","first-page":"10952","DOI":"10.1016\/S0021-9258(19)86616-4","article-title":"The contribution of bovine factor V and factor Va to the activity of prothrombinase","volume":"254","author":"Nesheim","year":"1979","journal-title":"J Biol Chem"},{"issue":"8","key":"2019111607195916200_B7","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1074\/jbc.273.8.4378","article-title":"Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor","volume":"273","author":"Baugh","year":"1998","journal-title":"J Biol Chem"},{"issue":"6215","key":"2019111607195916200_B8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/338518a0","article-title":"Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor","volume":"338","author":"Girard","year":"1989","journal-title":"Nature"},{"issue":"5","key":"2019111607195916200_B9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/jth.12188","article-title":"Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)\u03b1 and TFPI\u03b2","volume":"11","author":"Maroney","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"44","key":"2019111607195916200_B10","doi-asserted-by":"crossref","first-page":"17838","DOI":"10.1073\/pnas.1310444110","article-title":"Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation","volume":"110","author":"Wood","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"2019111607195916200_B11","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1016\/S0021-9258(18)68737-X","article-title":"Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains","volume":"263","author":"Wun","year":"1988","journal-title":"J Biol Chem"},{"issue":"9","key":"2019111607195916200_B12","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/j.1538-7836.2012.04834.x","article-title":"The C-terminus of tissue factor pathway inhibitor \u03b1 is required for its interaction with factors V and Va","volume":"10","author":"Ndonwi","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2019111607195916200_B13","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1021\/bi00457a004","article-title":"Activation of human factor V by factor Xa and thrombin","volume":"29","author":"Monkovic","year":"1990","journal-title":"Biochemistry"},{"issue":"pt 1","key":"2019111607195916200_B14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1042\/bj3230033","article-title":"Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor","volume":"323","author":"Franssen","year":"1997","journal-title":"Biochem J"},{"issue":"5","key":"2019111607195916200_B15","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1182\/blood.V87.5.1845.1845","article-title":"Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase","volume":"87","author":"Mast","year":"1996","journal-title":"Blood"},{"issue":"2","key":"2019111607195916200_B16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0005-2744(79)90103-7","article-title":"The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V","volume":"571","author":"Walker","year":"1979","journal-title":"Biochim Biophys Acta"},{"issue":"50","key":"2019111607195916200_B17","doi-asserted-by":"crossref","first-page":"31869","DOI":"10.1016\/S0021-9258(18)31776-9","article-title":"The mechanism of inactivation of human factor V and human factor Va by activated protein C","volume":"269","author":"Kalafatis","year":"1994","journal-title":"J Biol Chem"},{"issue":"8","key":"2019111607195916200_B18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJM199402243300801","article-title":"Resistance to activated protein C as a basis for venous thrombosis","volume":"330","author":"Svensson","year":"1994","journal-title":"N Engl J Med"},{"issue":"8912","key":"2019111607195916200_B19","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(94)92940-8","article-title":"Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis","volume":"343","author":"Z\u00f6ller","year":"1994","journal-title":"Lancet"},{"issue":"6475","key":"2019111607195916200_B20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"issue":"8","key":"2019111607195916200_B21","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1074\/jbc.270.8.4053","article-title":"Characterization of the molecular defect in factor VR506Q","volume":"270","author":"Kalafatis","year":"1995","journal-title":"J Biol Chem"},{"issue":"1","key":"2019111607195916200_B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181faa0f2","article-title":"Factor V Leiden thrombophilia","volume":"13","author":"Kujovich","year":"2011","journal-title":"Genet Med"},{"issue":"12","key":"2019111607195916200_B23","doi-asserted-by":"crossref","first-page":"7983","DOI":"10.1074\/jbc.272.12.7983","article-title":"Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor","volume":"272","author":"van \u2019t Veer","year":"1997","journal-title":"J Biol Chem"},{"issue":"33","key":"2019111607195916200_B24","doi-asserted-by":"crossref","first-page":"20721","DOI":"10.1074\/jbc.272.33.20721","article-title":"Increased tissue factor-initiated prothrombin activation as a result of the Arg506--> Gln mutation in factor VLEIDEN","volume":"272","author":"van \u2019t Veer","year":"1997","journal-title":"J Biol Chem"},{"issue":"18","key":"2019111607195916200_B25","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1161\/01.CIR.0000017361.39256.82","article-title":"Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden","volume":"105","author":"Eitzman","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"2019111607195916200_B26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<175::AID-AJH1>3.0.CO;2-X","article-title":"Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives","volume":"60","author":"Harris","year":"1999","journal-title":"Am J Hematol"},{"issue":"8990","key":"2019111607195916200_B27","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"issue":"6","key":"2019111607195916200_B28","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood.V85.6.1504.bloodjournal8561504","article-title":"High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)","volume":"85","author":"Rosendaal","year":"1995","journal-title":"Blood"},{"issue":"8935","key":"2019111607195916200_B29","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"issue":"15","key":"2019111607195916200_B30","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1021\/bi016058n","article-title":"Contribution of regions distal to glycine-160 to the anticoagulant activity of tissue factor pathway inhibitor","volume":"41","author":"Lockett","year":"2002","journal-title":"Biochemistry"},{"key":"2019111607195916200_B31","unstructured":"Morrissey JH . Morrissey laboratory protocol for preparing phospholipid vesicles (SUV) by sonication. 2001. Available at: http:\/\/tf7.org\/suv.pdf. Accessed May 2012."},{"issue":"23","key":"2019111607195916200_B32","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1182\/blood-2009-06-228940","article-title":"Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability","volume":"114","author":"Campbell","year":"2009","journal-title":"Blood"},{"issue":"7","key":"2019111607195916200_B33","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1073\/pnas.75.7.3085","article-title":"Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers","volume":"75","author":"Laudano","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2019111607195916200_B34","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1538-7836.2003.00153.x","article-title":"A monoclonal antibody against activated protein C allows rapid detection of activated protein C in plasma and reveals a calcium ion dependent epitope involved in factor Va inactivation","volume":"1","author":"Liaw","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2019111607195916200_B35","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1182\/blood-2006-07-037283","article-title":"Active tissue factor pathway inhibitor is expressed on the surface of coated platelets","volume":"109","author":"Maroney","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2019111607195916200_B36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.transci.2007.12.005","article-title":"Thrombin generation, fibrin clot formation and hemostasis","volume":"38","author":"Wolberg","year":"2008","journal-title":"Transfus Apheresis Sci"},{"issue":"31","key":"2019111607195916200_B37","doi-asserted-by":"crossref","first-page":"26342","DOI":"10.1074\/jbc.M112.377168","article-title":"A bipartite autoinhibitory region within the B-domain suppresses function in factor V","volume":"287","author":"Bos","year":"2012","journal-title":"J Biol Chem"},{"issue":"20","key":"2019111607195916200_B38","doi-asserted-by":"crossref","first-page":"15033","DOI":"10.1074\/jbc.M701315200","article-title":"Inhibitory sequences within the B-domain stabilize circulating factor V in an inactive state","volume":"282","author":"Zhu","year":"2007","journal-title":"J Biol Chem"},{"issue":"6","key":"2019111607195916200_B39","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1172\/JCI117623","article-title":"Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C","volume":"94","author":"Z\u00f6ller","year":"1994","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111607195916200_B40","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1073\/pnas.91.4.1396","article-title":"Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V","volume":"91","author":"Dahlb\u00e4ck","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"29","key":"2019111607195916200_B41","doi-asserted-by":"crossref","first-page":"18735","DOI":"10.1016\/S0021-9258(17)32228-7","article-title":"Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa","volume":"269","author":"Shen","year":"1994","journal-title":"J Biol Chem"},{"issue":"8","key":"2019111607195916200_B42","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1182\/blood.V93.8.2552","article-title":"Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V","volume":"93","author":"Thorelli","year":"1999","journal-title":"Blood"},{"issue":"1","key":"2019111607195916200_B43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000315141","article-title":"Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va","volume":"37","author":"Cramer","year":"2010","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"11","key":"2019111607195916200_B44","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1182\/blood-2002-10-3188","article-title":"Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis","volume":"101","author":"Dahm","year":"2003","journal-title":"Blood"},{"issue":"11","key":"2019111607195916200_B45","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1182\/blood-2014-08-592733","article-title":"A novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function","volume":"125","author":"Cunha","year":"2015","journal-title":"Blood"},{"issue":"9","key":"2019111607195916200_B46","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2008-06-162453","article-title":"Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency","volume":"112","author":"Duckers","year":"2008","journal-title":"Blood"},{"issue":"9","key":"2019111607195916200_B47","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1172\/JCI69091","article-title":"Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPI\u03b1","volume":"123","author":"Vincent","year":"2013","journal-title":"J Clin Invest"},{"issue":"5","key":"2019111607195916200_B48","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1055\/s-0037-1615717","article-title":"The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial","volume":"85","author":"H\u00f8ibraaten","year":"2001","journal-title":"Thromb Haemost"},{"issue":"6","key":"2019111607195916200_B49","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood.V72.6.2020.2020","article-title":"Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor","volume":"72","author":"Novotny","year":"1988","journal-title":"Blood"},{"issue":"1","key":"2019111607195916200_B50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/bjh.14182","article-title":"Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins","volume":"175","author":"Wood","year":"2016","journal-title":"Br J Haematol"},{"issue":"19","key":"2019111607195916200_B51","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1182\/blood-2013-11-512764","article-title":"Biology of tissue factor pathway inhibitor","volume":"123","author":"Wood","year":"2014","journal-title":"Blood"},{"issue":"42","key":"2019111607195916200_B52","doi-asserted-by":"crossref","first-page":"30151","DOI":"10.1074\/jbc.M113.506840","article-title":"Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides","volume":"288","author":"Bunce","year":"2013","journal-title":"J Biol Chem"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/6\/386\/878146\/advances002295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/6\/386\/878146\/advances002295.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T02:49:09Z","timestamp":1658630949000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/6\/386\/15608\/Reduced-prothrombinase-inhibition-by-tissue-factor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,13]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,2,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2016002295","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,13]]}}}